Latha Vankeepuram - Concepedia

Author

Latha Vankeepuram

Becton Dickinson (United States)

Also Known As

L. Vankeepuram, Latha Vankeepuram

Publications

390

Citations

H-Index

Concepts

All Affiliations

Becton Dickinson (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Latha Vankeepuram is an author at Becton Dickinson (United States) specializing in clinical microbiology, infection control, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	105
2	Health Sciences	1	1	61
3	Epidemiology	1	1	61
4	Hospital Medicine	1	1	44
5	Antibiotics	1	1	61

Latha Vankeepuram

Publications

377

Citations

H-Index

Page 1

	Year	Citations
Blood Culture Turnaround Time in U.S. Acute Care Hospitals and Implications for Laboratory Process Optimization Ying P. Tabak, Latha Vankeepuram, Gang Ye, Journal of Clinical Microbiology	2018	144
Incremental clinical and economic burden of suspected respiratory infections due to multi-drug-resistant Pseudomonas aeruginosa in the United States Ying P. Tabak, Sanjay Merchant, G. Ye, Journal of Hospital Infection Multi-drug-resistant Pseudomonas AeruginosaHealth SciencesAntibioticsHealthcare-associated InfectionRespiratory Infection	2019	61
Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections Ying P. Tabak, Anita Sung, G. Ye, Journal of Hospital Infection Healthcare-associated InfectionHospital EpidemiologyEconomic BurdenInfection ControlCarbapenem-non-susceptible Gram-negative Infections	2018	44
A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19 Laura Puzniak, Lyn Finelli, Kalvin Yu, BMC Infectious Diseases	2021	43
<p>Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Urinary Tract Infections</p> Eilish McCann, Anita Sung, Gang Ye, ClinicoEconomics and Outcomes Research	2020	31
Effect of Inadequate Empiric Antibacterial Therapy on Hospital Outcomes in SARS-CoV-2-Positive and -Negative US Patients With a Positive Bacterial Culture: A Multicenter Evaluation From March to November 2020 Laura Puzniak, Karri A. Bauer, Kalvin Yu, Open Forum Infectious Diseases	2021	30
Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections Ying P. Tabak, Anita Sung, Gang Ye, PLoS ONE	2020	12
<p>Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Respiratory Infections</p> Eilish McCann, Anita Sung, Gang Ye, Infection and Drug Resistance	2020	12

Page 1